JPMorgan Chase & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,869
| Closed | -$943K | – | 6568 |
|
|
2024
Q2 | $943K | Buy |
34,869
+599
| +2% | +$16.2K | ﹤0.01% | 3546 |
|
|
2024
Q1 | $628K | Sell |
34,270
-74,368
| -68% | -$1.36M | ﹤0.01% | 3826 |
|
|
2023
Q4 | $1.33M | Buy |
108,638
+38,234
| +54% | +$469K | ﹤0.01% | 3368 |
|
|
2023
Q3 | $1.06M | Sell |
70,404
-37,808
| -35% | -$567K | ﹤0.01% | 3370 |
|
|
2023
Q2 | $3.52M | Sell |
108,212
-97,248
| -47% | -$3.16M | ﹤0.01% | 2715 |
|
|
2023
Q1 | $8.04M | Buy |
205,460
+102,661
| +100% | +$4.02M | ﹤0.01% | 2154 |
|
|
2022
Q4 | $5.43M | Sell |
102,799
-12,300
| -11% | -$650K | ﹤0.01% | 2322 |
|
|
2022
Q3 | $5.18M | Sell |
115,099
-3,411
| -3% | -$154K | ﹤0.01% | 2317 |
|
|
2022
Q2 | $4.31M | Buy |
118,510
+48,951
| +70% | +$1.78M | ﹤0.01% | 2497 |
|
|
2022
Q1 | $2.87M | Sell |
69,559
-337
| -0.5% | -$13.9K | ﹤0.01% | 2943 |
|
|
2021
Q4 | $2.98M | Sell |
69,896
-11,958
| -15% | -$509K | ﹤0.01% | 2938 |
|
|
2021
Q3 | $4.51M | Sell |
81,854
-3,293
| -4% | -$181K | ﹤0.01% | 2656 |
|
|
2021
Q2 | $4.08M | Sell |
85,147
-12,842
| -13% | -$615K | ﹤0.01% | 2784 |
|
|
2021
Q1 | $4.96M | Buy |
97,989
+42,129
| +75% | +$2.13M | ﹤0.01% | 2653 |
|
|
2020
Q4 | $3.52M | Buy |
55,860
+44,919
| +411% | +$2.83M | ﹤0.01% | 2637 |
|
|
2020
Q3 | $746K | Sell |
10,941
-1,523
| -12% | -$104K | ﹤0.01% | 3216 |
|
|
2020
Q2 | $521K | Sell |
12,464
-14,411
| -54% | -$602K | ﹤0.01% | 3281 |
|
|
2020
Q1 | $847K | Buy |
26,875
+16,761
| +166% | +$528K | ﹤0.01% | 3033 |
|
|
2019
Q4 | $408K | Buy |
10,114
+3,879
| +62% | +$156K | ﹤0.01% | 3519 |
|
|
2019
Q3 | $203K | Buy |
6,235
+3,023
| +94% | +$98.4K | ﹤0.01% | 3740 |
|
|
2019
Q2 | $149K | Buy |
+3,212
| New | +$149K | ﹤0.01% | 3875 |
|